Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1Ovarian Carcinosarcoma 1Noonan Syndrome 5 1Neoplasms 1Hematologic Neoplasms 1Cardiovascular Diseases 1Advanced Solid Tumor 1

Interventions

Oxaliplatin 11Fluorouracil 10Capecitabine 9Leucovorin 7Radiotherapy 6Nivolumab 6Cetuximab 5Magnetic Resonance Spectroscopy 4Specimen Handling 3Radiation 3Bevacizumab 3sintilimab 2pembrolizumab 2fludarabine 2encorafenib 2dostarlimab 2aldesleukin 2Trastuzumab 2Tomography, X-Ray Computed 2Surveys and Questionnaires 2Surgical Procedures, Operative 2Sigmoidoscopy 2Radiotherapy, Intensity-Modulated 2Pemetrexed 2Magnetic Resonance Imaging 2Irinotecan 2Gemcitabine 2Folfox protocol 2Endoscopy 2Electrocardiography 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Antineoplastic Agents × 30 days × Clear all
NCT07594925 2026-05-19

Short-Course Radiotherapy Followed by Immunotherapy Combined With Chemotherapy for Microsatellite Stable Locally Advanced Rectal Cancer: A Prospective, Randomized, Controlled Phase II Clinical Trial

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Recruiting
130 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡